Showing 5211-5220 of 19420 results for "".
Disparities in Osteoporosis Care: Addressing Screening and Treatment Barriers
https://reachmd.com/programs/frontlines-osteoporosis/disparities-in-osteoporosis-care-addressing-screening-and-treatment-barriers/32335/Patients from diverse racial and ethnic backgrounds face several barriers when accessing osteoporosis screening and treatment, including lack of awareness and transportation. That’s why tailored educational and systematic interventions are needed to address these racial disparities in osteoporosis cMind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
https://reachmd.com/programs/neurofrontiers/mind-matters-psychiatric-comorbidity-in-the-prodromal-phase-of-ms/16269/A recent study investigated if psychiatric conditions can be an early predictor of MS. Let's dive into the findings.How to Set Up a Bladder Health Program
https://reachmd.com/programs/partners-in-practice/how-to-set-up-a-bladder-health-program/5751/More than 33 million people in the United States suffer from overactive bladder problems. Bladder health programs are being established in existing and new clinics to treat this issue that is rapidly growing, especially among the elderly. NP Helen Carcio began a certification program on the internetPioneering a First in Robotic Liver Transplant
https://reachmd.com/programs/medical-industry-feature/pioneering-a-first-in-robotic-liver-transplant/29920/Learn more about the innovations that led to the first fully robotic liver transplant in New York and how it is transforming the future of surgery.New 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery
https://reachmd.com/programs/medical-industry-feature/new-3d-mri-technology-offers-enhanced-visibility-during-fibroid-surgery/29918/Learn more about a novel 3D MRI technology that is helping surgeons detect and remove fibroids more accurately than traditional imaging.Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
https://reachmd.com/programs/neurofrontiers/negative-symptoms-in-schizophrenia/39940/Negative symptoms of schizophrenia—such as emotional flatness, social withdrawal, and lack of motivation—are often subtle, persistent, and underrecognized, yet they significantly impact patient functioning and quality of life. To learn more about this hidden burden, Dr. Alexandria May speaks with DrLearning, Laughing, and Living with Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/learning-laughing-and-living-with-multiple-sclerosis/37228/Ardra Shephard, a musician, author, fashion-show TV host, podcaster, and MS advocate, discusses her experiences living with MS, including how she uses her story to educate and encourage others living with MS. She is joined by Jiwon Oh, MD, Medical Director of the Barlo Multiple Sclerosis Program atManaging Perimenopausal Bleeding with Evidence-Based Options
https://reachmd.com/programs/advances-in-womens-health/managing-perimenopausal-bleeding-evidence-based-options/48739/Unpredictable and heavy bleeding is a common yet distressing symptom of perimenopause. With a range of options available, selecting the right treatment requires a careful, individualized approach. Joining Dr. Mary Katherine Cheeley to discuss patient-centered strategies for managing perimenopausal bAdvances in Disease-Modifying and Curative Therapies for Sickle Cell Disease
https://reachmd.com/programs/project-oncology/advances-in-disease-modifying-and-curative-therapies-for-sickle-cell-disease/35928/Sickle cell disease management traditionally involves two primary treatment approaches: disease-modifying therapies and curative strategies. While disease-modifying therapies can help reduce complications associated with the disease, they do not correct or fix them, which is why curative strategiesBiomarker Predicts Response to BCMA CAR T-Cell Therapy in Multiple Myeloma
https://reachmd.com/programs/medical-industry-feature/biomarker-predicts-response-to-bcma-car-t-cell-therapy-in-multiple-myeloma/29919/Discover how measuring ALC after CAR T-cell therapy injection for multiple myeloma can help predict a patient response and improve treatment planning.